On January 4, 2022 Caris Life Sciences (Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, reported that the Company will present at the 40th Annual J.P. Morgan Healthcare Conference, which is being held virtually on January 10-13, 2022 (Press release, Caris Life Sciences, JAN 4, 2022, View Source [SID1234598154]). Caris will be presenting via the live conference webcast on January 11, at 11:30 a.m. ET, and will provide an overview of the business and discuss recent corporate achievements that position the organization to further extend its leadership position in the market.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Caris will be represented by David D. Halbert, Chairman and Chief Executive Officer, Brian J. Brille, Vice Chairman, David Spetzler, MS, MBA, Ph.D., President and Chief Scientific Officer, Mike Weinstein, Executive Vice President and Chief Financial Officer and Brian Lamon, Ph.D., Chief Business Officer, Head of BioPharma Business Development.